Which Blood Sugar Meds Work Best Against Type 2 Diabetes?
TUESDAY, June 29, 2021 -- You have type 2 diabetes, and you are already taking an old standby drug, metformin. But you still need help controlling your blood sugar levels. Which medication would be the best?
New research pitted several diabetes... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 29, 2021 Category: General Medicine Source Type: news
' Stunning' Twincretin Beats Semaglutide in Type 2 Diabetes'Stunning' Twincretin Beats Semaglutide in Type 2 Diabetes
Head-to-head pivotal trial results show weekly tirzepatide injections surpassed 1 mg semaglutide weekly for A1c reduction and weight loss as second-line therapy after metformin in type 2 diabetes.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - June 27, 2021 Category: Cardiology Tags: Diabetes & Endocrinology News Source Type: news
Discontinuing Metformin: The Crowdsourced View Discontinuing Metformin: The Crowdsourced View
Readers were divided on the decision to stop an elderly woman ' s metformin and reduce her pill burden.Medscape Family Medicine (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - June 23, 2021 Category: Primary Care Tags: Family Medicine/Primary Care Article Source Type: news
FDA Recalls More Metformin Extended-Release Tablets FDA Recalls More Metformin Extended-Release Tablets
Two lots of metformin HCl extended-release tablets have been recalled by Viona Pharmaceuticals because unacceptable levels of nitrosodimethylamine, a likely carcinogen, were found in the 750-mg tablets.News Alerts (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - June 15, 2021 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Alert Source Type: news
Viona Pharmaceuticals Inc., Issues Voluntary Nationwide Recall of Metformin HCl Extended-Release Tablets, USP 750 mg, Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity
Viona Pharmaceuticals Inc., is voluntarily recalling 2 (two) lots of Metformin Hydrochloride Extended-Release Tablets, USP 750 mg to the retail level. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 11, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Common diabetes drug shows promise as treatment for COVID-19 lung inflammation
Metformin is a widely prescribed blood sugar-lowering drug. It is often used as an early therapy (in combination with diet and lifestyle changes) for type 2 diabetes, which afflicts more than 34 million Americans.
Metformin works by lowering glucose production in the liver, reducing blood sugar levels that, in turn, improve the body's response to insulin. (Source: World Pharma News)
Source: World Pharma News - June 10, 2021 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Common diabetes drug shows promise as treatment for COVID-19 lung inflammation
(University of California - San Diego) Researchers identify molecular mechanism for the anti-inflammatory activity of diabetes drug metformin and, in mouse studies, say it prevents lung inflammation in animals infected with SARS-CoV-2, the virus that causes COVID-19. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 10, 2021 Category: Infectious Diseases Source Type: news
' Remarkable' Response to Diabetes Drug for Bipolar Depression'Remarkable' Response to Diabetes Drug for Bipolar Depression
Patients with treatment-resistant bipolar depression with insulin resistance showed marked improvement in depressive symptoms after their insulin-resistance was mitigated by treatment with metformin.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - June 7, 2021 Category: Internal Medicine Tags: Psychiatry News Source Type: news
AstraZeneca Pharma, Abbott Healthcare terminate distribution agreements for diabetes drug in India
AstraZeneca India will continue to independently market Dapagliflozin, the combinations of Dapagliflozin and Metformin as well as Dapagliflozin and Saxagliptin in India under the brand names Forxiga, Xigduo and Qtern respectively, the filing said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 28, 2021 Category: Pharmaceuticals Source Type: news
U of M Medical School receives $1.5M for nation's first ivermectin COVID-19 clinical trial
(University of Minnesota Medical School) An ongoing COVID-19 clinical trial studying the outpatient use of metformin, a generic medication for type 2 diabetes, has expanded and will now be the nation's first to include fluvoxamine, an antidepressant, and ivermectin, an antiparasitic, as possible treatment options to prevent hospitalization and " long COVID. " (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 25, 2021 Category: International Medicine & Public Health Source Type: news
Sun Pharma recalls 50,868 bottles of diabetes drug in US
Drug major Sun Pharma is recalling 50,868 bottles of diabetes drug Metformin HCl extended-release tablets in the US market, according to the US Food and Drug Administration (USFDA). (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 21, 2021 Category: Pharmaceuticals Source Type: news
Right Time to Deprescribe This Frail Patient's Metformin? Right Time to Deprescribe This Frail Patient's Metformin?
Check out this case, and see whether you agree with Dr Vega ' s opinion on deprescribing metformin in an elderly patient.Medscape Family Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 20, 2021 Category: Consumer Health News Tags: Family Medicine/Primary Care Article Source Type: news
Diabetes drug shows potential in fighting cancer
(Massachusetts General Hospital) Phenformin, in combination with immunotherapies like PD-1 immune checkpoint inhibitors, shows greater promise than phenformin or metformin alone. A clinical trial is under way at MGH to evaluate the use of phenformin with an inhibitor of the BRAF-mutated gene, present in roughly half of all melanomas. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 14, 2021 Category: Cancer & Oncology Source Type: news
How to live longer: Anti-diabetic drug shown to reduce cancer risk to boost longevity
HOW TO live longer could be as simple as popping a pill daily, according to studies. Metformin has shown impressive results to help not only reduce cancer and cardiovascular disease risk, but also in helping to delay the ageing process. How? (Source: Daily Express - Health)
Source: Daily Express - Health - April 6, 2021 Category: Consumer Health News Source Type: news
Diabetes drug may be a new weapon against HIV
(University of North Carolina Health Care) A team led by scientists at the UNC School of Medicine discovered an important vulnerability of the AIDS-causing retrovirus HIV, and has shown in preclinical experiments that a widely used diabetes drug, metformin, seems able to exploit this vulnerability. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 29, 2021 Category: International Medicine & Public Health Source Type: news
